Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 413-419 , March 2009

Endothelial dysfunction in adiponectin deficiency and its mechanisms involved

  • Yu Cao

      Affiliations

    • Department of Emergency Medicine, West China Hospital, Sichuan University, Cheng-Du, People's Republic of China
    • Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • The first two authors contributed equally to the study.
    • ,
  • Ling Tao

      Affiliations

    • Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • The first two authors contributed equally to the study.
    • ,
  • Yuexing Yuan

      Affiliations

    • Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • ,
  • Xiangying Jiao

      Affiliations

    • Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • ,
  • Wayne Bond Lau

      Affiliations

    • Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • ,
  • Yajing Wang

      Affiliations

    • Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • ,
  • Theodore Christopher

      Affiliations

    • Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • ,
  • Bernard Lopez

      Affiliations

    • Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • ,
  • Lawrence Chan

      Affiliations

    • Section of Diabetes, Endocrinology and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    • ,
  • Barry Goldstein

      Affiliations

    • Division of Endocrinology, Diabetes and Metabolic Diseases, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • ,
  • Xin L. Ma

      Affiliations

    • Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
    • Corresponding Author InformationCorresponding author. Department of Emergency Medicine, 1020 Sansom Street, Thompson Building, Room 241, Philadelphia, PA 19107, USA. Tel.: +1 215 955 4994; fax: +1 215 923 6225.

Received 23 September 2008 ,Revised 20 October 2008 ,Accepted 22 October 2008.

References 

  1. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115(1):114–126
  2. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr. Rev. 2001;22(1):36–52
  3. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 2005;26(3):439–451
  4. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000;20(6):1595–1599
  5. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Lowel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J. Am. Coll. Cardiol. 2006;48(7):1369–1377
  6. Goldstein BJ, Scalia R. Adipokines and vascular disease in diabetes. Curr. Diab. Rep. 2007;7(1):25–33
  7. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin. Sci. (Lond). 2008;114(5):361–374
  8. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003;42(3):231–234
  9. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J. Clin. Endocrinol. Metab. 2003;88(7):3236–3240
  10. Tan KCB, Xu A, Chow WS, Lam MCW, Ai VHG, Tam SCF, et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J. Clin. Endocrinol. Metab. 2004;89(2):765–769
  11. Maruyoshi H, Kojima S, Otsuka F, Funahashi T, Kaikita K, Sugiyama S, et al. Hypoadiponectinemia is associated with coronary artery spasm in men. Circ. J. 2005;69(9):1154–1156
  12. Lund DD, Faraci FM, Miller FJ, Heistad DD. Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation. 2000;101(9):1027–1033
  13. Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation. 2007;115(11):1408–1416
  14. Liang F, Gao E, Tao L, Liu H, Qu Y, Christopher TA, et al. Critical timing of l-arginine treatment in post-ischemic myocardial apoptosis-role of NOS isoforms. Cardiovasc. Res. 2004;62(3):568–577
  15. Liu HR, Tao L, Gao E, Lopez BL, Christopher TA, Willette RN, et al. Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc. Res. 2004;62(1):135–144
  16. Cotter MA, Cameron NE. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci. 2003;73(14):1813–1824
  17. Tanaka K, Honda M, Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J. Am. Coll. Cardiol. 2001;37(2):676–685
  18. Lamas S, Lowenstein CJ, Michel T. Nitric oxide signaling comes of age: 20 years and thriving. Cardiovasc. Res. 2007;75(2):207–209
  19. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell. Mol. Life Sci. 1999;55(8–9):1078–1087
  20. Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc. Res. 2000;47(3):457–464
  21. Goldberg IJ. Why does diabetes increase atherosclerosis? I don't know!. J. Clin. Invest. 2004;114(5):613–615
  22. Busse R, Fleming I. Endothelial dysfunction in atherosclerosis. J. Vasc. Res. 1996;33:181–194
  23. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 2002;277(29):25863–25866
  24. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 2003;278(45):45021–45026
  25. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am. J. Physiol. Heart. Circ. Physiol. 2006;291(3):H985–1002
  26. Li R, Wang WQ, Zhang H, Yang X, Fan Q, Christopher TA, et al. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Am. J. Physiol. Endocrinol. Metab. 2007;293(6):E1703–E1708
  27. Motoshima H, Wu X, Mahadev K, Goldstein BJ. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem. Biophys. Res. Commun. 2004;315(2):264–271
  28. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 2000;87(10):840–844
  29. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 2008;102(4):488–496
  30. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 1993;91:2546–2551
  31. Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjoquist PO, et al. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovasc. Res. 2008;78(1):116–122
  32. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 2002;277(40):37487–37491
  33. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;106(22):2767–2770
  34. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 2003;278(4):2461–2468
  35. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension. 2006;47(6):1108–1116

PII: S0022-2828(08)01371-0

doi: 10.1016/j.yjmcc.2008.10.014

Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 413-419 , March 2009

Article Tools

* Image Usage & Resolution